ADORA2A and Alzheimer disease: Moreover, the present observation that A2AR blockade prevents both the initial hyperexcitability during the presymptomatic phase of AD and the opposite decreased synaptic plasticity emerging with the onset of memory deficits confirms the prophylactic and therapeutic potential of A2AR antagonists and stresses the need to understand the different signaling mechanisms operated by A2AR in different cellular compartments.